Repayment Obligation (340B)
Definition
A repayment obligation arises when an HRSA audit identifies that a covered entity received 340B pricing on drug purchases that did not comply with program requirements. The most common triggers are diversion (dispensing 340B drugs to ineligible patients) and duplicate discounts (receiving both a 340B price reduction and a Medicaid rebate on the same drug).
The repayment amount is calculated based on the value of the improperly obtained 340B savings over the period of non-compliance. For systemic violations over extended periods, repayment obligations can be substantial. Repayment is typically required as part of a Corrective Action Plan.
Repayment obligations underscore why proactive compliance investment is financially prudent. The cost of independent audits, continuous monitoring, and compliance consulting is almost always a fraction of the potential repayment exposure from undetected violations.
Frequently Asked Questions
Why Repayment Obligation (340B) Matters
Repayment obligations can represent years of improperly obtained savings. For covered entities with high 340B volumes, even a small percentage of non-compliant transactions over an extended period can result in significant financial exposure. Prevention is far less costly than remediation.
How Virtue 340B Uses It
Virtue 340B helps covered entities identify and remediate compliance gaps before they accumulate into repayment-level exposure. Our audit and monitoring services are specifically designed to catch issues early, when they are still manageable.